Belviq Settlement Discussions Underway, as Cases Put on Hold
Judge approved a four month stay in a Belviq lawsuit, while parties explore global settlement negotiations to resolve cancer claims over the recalled diet drug
Judge approved a four month stay in a Belviq lawsuit, while parties explore global settlement negotiations to resolve cancer claims over the recalled diet drug
A federal judge ruled the plaintiff's complaint contained enough details to support pursuing most of her Belviq colon cancer claims under Ohio law.
Belviq diet pills were recalled in 2020 due to their link to an increased risk of various forms of cancer.
Side effects of the diet pill led to a recall in 2020. However, new lawsuits continue to be filed over cancer caused by Belviq.
Belviq was recalled in Feb. 2020, after just eight years on the market. However, lawsuit indicates diet pill makers knew or should have known about the link between Belviq and cancer much earlier
The diet drug was recalled early last year following preliminary clinical trial data linking it to an increased risk of cancer, and sparking hundreds of Belviq lawsuits.
Plaintiff was unware of recalled diet drug's link to increased thyroid cancer risk until several years after her diagnosis.
Manufacturers knew about the risk of cancer caused by Belvic since at least 2012, but continued to sell the recalled diet drug, according to lawsuit
Court rejected motion to dismiss claims filed by a former user who alleges maker of the diet drug failed to adequately warn about the link between Belviq and cancer, which resulted in a global recall in early 2020.
After using the weight loss drug for nearly two years, a woman indicates she was diagnosed with colon cancer from Belviq months before it was recalled.